AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Understanding different investment methods is key to retirement planning. Discover three strategies to grow your retirement savings efficiently.
18,777 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
President Trump signed proclamations shrinking Bears Ears and Grand Staircase-Escalante monuments by roughly 90%, sig...
As the 2026 World Cup unfolds, France stands to collect a sizable prize pot regardless of results. Meanwhile, Mbappé ...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
Bitcoin and Ethereum start 2026 with steep losses, marking their worst year-to-date performance in a decade. Analysts...
A timely macro rebuttal from Citadel Securities challenges a viral AI-doomsday scenario, arguing that current data sh...
A rising productivity framework argues that some workplace tasks look busy but deliver little real value. This could ...
The Pentagon has formally designated Anthropic as a supply chain risk, a move that could curtail access to defense co...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
In a higher-rate market, four ETFs are delivering standout income. This report breaks down JEPI, BIZD, SDIV and KNG, ...
More than 3,800 workers at a large Colorado meatpacking plant walked off Monday, marking the first major U.S. beef sl...
A growing share of Americans are drawn to traveling alone, even as hesitation persists. This guide breaks down the fi...